6. — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16…

6.

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

When a temporarily halted clinical trial referred to in paragraph 5 is resumed the sponsor shall notify each Member State concerned through the EU portal. That notification shall be made within 15 days from the restart of the temporarily halted clinical trial in all Member States concerned.

← art_37__para_5__text_2 · All articles · art_37__para_6__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.